Insider Transactions last 24 months for Cytokinetics, Incorporated  -  NSDQ: CYTK

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Callos AndrewEVP, Chief Commercial Officer03/31/2026DSDirectCOM3,639$65.00$236,535.0066,004
Callos AndrewEVP, Chief Commercial Officer03/18/2026DSDirectCOM1,930$62.07$119,795.1078,185
Blum Robert IPresident & CEO03/17/2026DSDirectCOM23,928$62.15$1,487,125.20430,330
Blum Robert IPresident & CEO03/17/2026DSDirectCOM12,673$62.15$787,626.95454,258
Malik Fady IbrahamEVP Research & Development03/17/2026DSDirectCOM4,397$62.15$273,273.55153,902
Malik Fady IbrahamEVP Research & Development03/17/2026DSDirectCOM7,636$62.15$474,577.40158,299
Callos AndrewEVP, Chief Commercial Officer03/17/2026DSDirectCOM2,916$62.15$181,229.4071,573
Callos AndrewEVP, Chief Commercial Officer03/17/2026DSDirectCOM5,626$62.15$349,655.9074,489
Lee SungEVP, Chief Financial Officer03/17/2026DSDirectCOM4,935$62.15$306,710.2587,127
Callos AndrewEVP, Chief Commercial Officer03/16/2026DSDirectCOM1,709$61.03$104,300.2746,149
Malik Fady IbrahamEVP Research & Development03/15/2026AADirectCOM27,306$0.00$0.00165,935
Lee SungEVP, Chief Financial Officer03/15/2026AADirectCOM20,646$0.00$0.0092,062
Hessekiel JeffreyChief Legal & Admin Officer03/15/2026AADirectCOM20,646$0.00$0.00107,943
Callos AndrewEVP, Chief Commercial Officer03/15/2026AADirectCOM13,320$0.00$0.0081,824
Callos AndrewEVP, Chief Commercial Officer03/15/2026AADirectCOM20,646$0.00$0.0068,504
Blum Robert IPresident & CEO03/15/2026AADirectCOM75,258$0.00$0.00466,931
Blum Robert IPresident & CEO03/09/2026DSDirectCOM7,931$60.72$481,570.32391,673
Malik Fady IbrahamEVP Research & Development03/09/2026DSDirectCOM2,907$60.72$176,513.04138,629
Callos AndrewEVP, Chief Commercial Officer03/09/2026DSDirectCOM2,582$60.72$156,779.0447,858
Callos AndrewEVP, Chief Commercial Officer03/05/2026AMDirectCOM15,000$23.26$348,900.0065,440
Callos AndrewEVP, Chief Commercial Officer03/05/2026DSDirectCOM11,000$61.88$680,680.0050,440
Callos AndrewEVP, Chief Commercial Officer03/05/2026DSDirectCOM15,000$61.87$928,050.0061,440
Callos AndrewEVP, Chief Commercial Officer03/05/2026AMDirectCOM11,000$39.13$430,430.0076,440
Callos AndrewEVP, Chief Commercial Officer03/02/2026DSDirectCOM886$61.62$54,595.3250,440
Callos AndrewEVP, Chief Commercial Officer03/02/2026AMDirectCOM886$37.63$33,340.1851,326
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 14 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel